Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series

被引:0
|
作者
Katsuhisa Ohgi
Yusuke Yamamoto
Teiichi Sugiura
Yukiyasu Okamura
Takaaki Ito
Ryo Ashida
Takeshi Aramaki
Katsuhiko Uesaka
机构
[1] Shizuoka Cancer Center,Division of Hepato
[2] Shizuoka Cancer Center,Biliary
来源
关键词
Venous Involvement; Borderline Resectable Pancreatic Cancer (BRPC); Positive Peritoneal Lavage Cytology; Unresectable Group; Venereal Contact;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2752 / 2761
页数:9
相关论文
共 50 条
  • [41] Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
    Choi, Young Hoon
    Hong, Tae Ho
    Yoon, Seung Bae
    Lee, In Seok
    Lee, Myung Ah
    Choi, Ho Joong
    Choi, Moon Hyung
    Jung, Eun Sun
    BIOMEDICINES, 2022, 10 (06)
  • [42] Prognostic implication of portal venous circulating tumor cells in resectable pancreatic cancer
    Yoon, S.
    Choi, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S298 - S299
  • [43] Neoadjuvant chemotherapy followed by surgery versus upfront surgery in patients with borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.
    Kang, Junho
    Yoo, Changhoon
    Shin, Sang Hyun
    Kim, Kyu-Pyo
    Jeong, Jae Ho
    Chang, Heung-Moon
    Lee, Sang Soo
    Park, Do Hyun
    Song, Tae Jun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Park, Jin-hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Ryoo, Baek-Yeol
    Kim, Song Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [44] Determining Optimal Routes to Surgery for Borderline Resectable Venous Pancreatic Cancer-Where Is the Least Harm and Most Benefit?
    Pande, Rupaly
    Roberts, Keith J.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [45] Evaluation of Completion Rate of 'Upfront Surgery and Adjuvant Chemotherapy' According to Resectable Status of Pancreatic Head Cancers
    Nara, Satoshi
    Shimada, Kazuaki
    Esaki, Minoru
    Kishi, Yoji
    Suto, Hironobu
    Kosuge, Tomoo
    GASTROENTEROLOGY, 2015, 148 (04) : S1146 - S1146
  • [46] Optimal timing of surgery after neoadjuvant treatment in borderline resectable pancreatic cancer
    Jung, Hye-Sol
    Kwon, Wooil
    Yun, Won-Gun
    Paik, Woo Hyun
    Lee, Sang Hyub
    Ryu, Ji Kon
    Oh, Do-Youn
    Lee, Kyoung Bun
    Chie, Eui Kyu
    Jang, Jin-Young
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2024, 31 (10) : 737 - 746
  • [47] Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
    Bockhorn, Maximilian
    Uzunoglu, Faik G.
    Adham, Mustapha
    Imrie, Clem
    Milicevic, Miroslav
    Sandberg, Aken A.
    Asbun, Horacio J.
    Bassi, Claudio
    Buechler, Markus
    Charnley, Richard M.
    Conlon, Kevin
    Cruz, Laureano Fernandez
    Dervenis, Christos
    Fingerhutt, Abe
    Friess, Helmut
    Gouma, Dirk J.
    Hartwig, Werner
    Lillemoe, Keith D.
    Montorsi, Marco
    Neoptolemos, John P.
    Shrikhande, Shailesh V.
    Takaori, Kyoichi
    Traverso, William
    Vashist, Yogesh K.
    Vollmer, Charles
    Yeo, Charles J.
    Izbicki, Jakob R.
    SURGERY, 2014, 155 (06) : 977 - 988
  • [48] Neoadjuvant Therapy Followed by Surgical Resection for Borderline Resectable Pancreatic Cancer With Artery Involvement
    Yamaue, Hiroki
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    GASTROENTEROLOGY, 2015, 148 (04) : S1164 - S1164
  • [49] The impact of lymphocyte-to-monocyte ratio (LMR) in patients with borderline resectable pancreatic head cancer after curative surgery
    Miyahara, Yoji
    Takano, Shigetsugu
    Yoshitomi, Hideyuki
    Kagawa, Shingo
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Suzuki, Daisuke
    Sakai, Nozomu
    Mishima, Takashi
    Nakadai, Eri
    Ohtsuka, Masayuki
    CANCER RESEARCH, 2019, 79 (24)
  • [50] BORDERLINE RESECTABLE PANCREATIC CANCER - A CONSENSUS STATEMENT BY THE INTERNATIONAL STUDY GROUP OF PANCREATIC SURGERY (ISGPS)
    Bockhorn, M.
    Uzunoglu, E. G.
    Izbicki, J. R.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6802 - 6802